Anabella Villalobos
Fortune : 45 600 $ au 31/08/2026
Fortune : 45 600 $ au 31/08/2026
Dr. Anabella Villalobos is an Independent Director at Coya Therapeutics, Inc. She is on the Board of Directors at Coya Therapeutics, Inc. Dr. Villalobos was previously employed as a SVP-Biotherapeutics & Medicinal Sciences by Biogen, Inc. and a Vice President by Pfizer Inc. She received her undergraduate degree from the University of Panama and a doctorate degree from the University of Kansas.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
COYA THERAPEUTICS, INC. 0,04 % | 01/05/2026 | 10 000 ( 0,04 % ) | 45 600 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| COYA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 25/05/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2025 |
| PFIZER INC. | Corporate Officer/Principal | 01/01/2017 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
University of Kansas
University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Panama
University of Panama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coya Therapeutics, Inc.
Coya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on research and development of therapies to enhance the function of regulatory T cells | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national